PLVAP and nonpapillary renal cell carcinoma: Building on this evidence, we evaluated whether PV-1 detection could serve as a marker for distant metastases also in other solid tumors known to metastasize via the hematogenous route, such as luminal breast cancer and clear cell renal cell carcinoma (ccRCC).